Drug intelligence / Profile preview

Phenindione

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

Phenindione is a synthetic oral anticoagulant that functions as a Vitamin K antagonist. It interferes with the formation of vitamin K-dependent clotting factors (II, VII, IX, and X) in the liver by inhibiting vitamin K reductase, leading to depletion of reduced vitamin K (vitamin KH2). This action reduces the blood's ability to clot. It is prescribed for thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and to reduce the risk of stroke in patients with atrial fibrillation. While it has actions similar to warfarin, it is less commonly used today due to a higher incidence of severe adverse effects, including hypersensitivity reactions.

Brand names
DindevanDaniloneHedulinDiophindaneAthrombonFenhydrenPhenylindanedionePhenylindioneDanedionDiadilanEmandionePhenhydrenPhenillinTheradioneBindanDinevalIndemaIndonFenindionHemolidioneDanilonEmandionPhenylenPhenylinTromazalTrombolCronodioneThrombasalFenindiona
Other names
2-Phenyl-1,3-indandione2-Phenyl-1H-indene-1,3(2H)-dionePhenylindanedione
02

Targets

VKORC1 (Vitamin K epoxide reductase complex subunit 1)

Beyond the preview

Go deeper on Phenindione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenindione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call